In compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018, (‘PIT Regulations’) and as per the Company's ‘Code of Conduct’, Syschem (India) has informed that the trading window for dealing in the securities of the Company shall remain closed for Directors/officers/Designated Persons and their immediate relatives as defined under the PIT Regulations and the said code, from Tuesday, October 01, 2024 till the expiry of 48 hours after the announcement of unaudited financial results of the company for the quarter ended on 30th September, 2024. The dates of the meeting of the Board of Directors of the Company to approve the unaudited financial results of the Company for the quarter ended 30th September, 2024 will be intimated in due course.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1800.15 |
Dr. Reddys Lab | 1220.20 |
Cipla | 1499.55 |
Lupin | 2107.45 |
Zydus Lifesciences | 956.70 |
View more.. |